Proceeds from the $39 million financing will be used to expand the treatment of Fragility Fractures of the Pelvis (FFP) throughout the U.S. and fundamentally change the course of care for these ...

IRVINE, CA, and HERSTAL, BELGIUM – 15 May 2020 – MDxHealth SA (Euronext Brussels: MDXH) (the "Company" or "MDxHealth"), a commercial-stage innovative molecular diagnostics company, announces today ...

Jack Tanaka, MVM Partner. MVM Partners joins as Avanzanite’s first institutional investor. Funding will scale Avanzanite’s existing infrastructure in all 32 countries in Europe, propel current ...

LONDON & BOSTON--(BUSINESS WIRE)--MVM Life Science Partners today announced the closing of a $233 million healthcare fund, MVM IV. The fund is MVM’s fourth and largest raised to date. MVM IV is ...

MVM Partners, LLC, a significant shareholder in Paragon 28, Inc. (NYSE:FNA), disclosed the sale of 48,270 shares of common stock over two days, according to a recent SEC filing. The transactions, ...

MVM Partners, LLC, a ten percent owner of Paragon 28 , Inc. (NYSE: FNA), recently disclosed the sale of 45,162 shares of the company's common stock. The transactions occurred over two consecutive days ...

Wilson Therapeutics, a biopharmaceutical company, today announced that it has closed a $40 million Series B financing co-led by new investors, Abingworth LLP and MVM Life Science Partners LLP (“MVM”).

IRVINE, CA, and HERSTAL, BELGIUM – 27 April 2020 – MDxHealth SA (Euronext Brussels: MDXH) (the "Company" or "MDxHealth") a commercial-stage innovative molecular diagnostics company, announces today ...

Since receiving FDA clearance in 2019, many designated US cancer centers have adopted icotec's BlackArmor® products. This investment will enable icotec to continue its impressive growth and strengthen ...

MVM Life Science Partners today announced the closing of a $233 million healthcare fund, MVM IV. The fund is MVM’s fourth and largest raised to date. MVM IV is investing in medical companies, ...